Immutep
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
IMMP Key Statistics
IMMP News
An update from Immutep Ltd ( (AU:IMM) ) is now available. UBS Group AG and its related entities have notified Immutep Ltd that they have ceased to be a substan...
Immutep ( (IMMP) ) has provided an announcement. On March 13, 2026, Immutep said an Independent Data Monitoring Committee recommended halting its TACTI-004 Pha...
Immutep Limited (NASDAQ:IMMP) shares are tumbling on Friday following the company’s update for the TACTI-004 Phase 3 trial. The Australia-based biotech announce...
Analyst ratings
71%
of 7 ratingsMore IMMP News
Maxim downgraded Immutep (IMMP) to Hold from Buy after the company’s Phase 3 study with Merck (MRK) of eftilagimod alfa in patients in first line non-small cell...
Immutep (IMMP) stock fell hard on Friday after the biotechnology company announced it would discontinue a Phase III clinical trial. This study was focused on ef...
Baird downgraded Immutep (IMMP) to Neutral from Outperform with a price target of $1, down from $7. The Independent Data Monitoring Committee recommended the di...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.